Business Wire

Vennetics and Reelgood Partner to Bring Apple TV+ Original Content to IPTV Providers

Del

As the OTT marketplace has exploded over the last few years, leading streaming providers like Netflix and Amazon have been increasingly focused on creating their own original content. Recently, Apple TV+, Disney+ and others have thrown their hat into the ring, which means more original titles and more choice for consumers. An increasingly fragmented VoD market, with each provider offering independent catalogues of their own original content, is generating an increased user demand for universal search and discovery features. To simplify the experience, Vennetics and Reelgood are introducing a new solution with support for all of the leading streaming providers, including the forthcoming Apple TV+ original content.

Vennetics has been delivering carrier-grade solutions to service providers such as Bell, H3G and Telkom Indonesia for more than 10 years, supporting mass market services in North America, Europe and Asia. The Vennetics MVP technology is also pre-integrated with all of the leading VoD platforms. This includes the business integration required to deliver a revenue share from OTT content, for the data network providers that carry these video streams. “Network providers have been making huge investments in data capacity, facilitating billion dollar streaming companies in delivering their products to end users. This Vennetics and Reelgood solution will allow network providers to earn a revenue share from the rapidly growing OTT premium VoD sector,” says John Hamill, Vennetics CEO.

Viewership for linear TV continues to decline and the growth of on-demand consumption continues unabated, such that service providers are responding with their own catch-up and on-demand capabilities. However, an on-demand catalogue merely consisting of the most ubiquitous movies and TV shows, will be inadequate for users who want to discover the latest original content. Streaming users want to select from the most compelling content with simplicity. Vennetics and Reelgood are meeting this need for service providers, including the new Apple TV+ catalogue and all of the other leading original VoD content, while supporting a business case that generates an incremental new revenue stream.

As the leading independent streaming guide for consumers, Reelgood already provides universal search and discovery for the US market. By aggregating OTT services into a unified interface, Reelgood solves the SVOD fragmentation problem on mobile, web, and, soon, many of the world’s major smartTVs. “As SVOD fragmentation continues to spike, consumers still want the same thing: the convenience of finding all of their content libraries in one place.”, says David Sanderson, Reelgood CEO. “We look forward to partnering with Vennetics to solve SVOD fragmentation in Europe”.

About Vennetics

Vennetics was founded in 2007 by a forward-looking team, with proven experience in both the communications and information technology industries. At Vennetics, we’re committed to providing our customers with the technology to launch relevant and engaging services, which delight their customers and meet their evolving entertainment and communication needs.

www.vennetics.com

About Reelgood

Reelgood provides the world's most extensive streaming guide, with every TV show and movie available to stream online. Browse through every TV series and movie and sort by title, release year, genre, IMDB rating and most important - see where to watch it. Then play with a single click or tap. From Starz, FX, Showtime, Hulu, HBO, Amazon Prime, Netflix, CBS, Cinemax, CrunchyRoll, to a free bundle that includes programs from sources like Crackle, ABC, Fox, NBC, Disney, now viewers have access to a massive library of watchable content—through one platform only! That’s Reelgood.

www.reelgood.com

Contact information

Vennetics
John Hamill
+353(0)429419624
john.hamill@vennetics.com
info@vennetics.com

Reelgood
David Sanderson
david@reelgood.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

The Smarter E Europe – Explore Sector Coupling for Yourself at Europe’s Largest Platform for the Energy Industry25.4.2019 09:53:00 CESTPressemelding

The innovation hub The smarter E Europe, encompassing the exhibitions Intersolar Europe, ees Europe, Power2Drive Europe and EM-Power, was launched in 2018 and has seen impressive growth ever since. It will be held for the second time from May 15–17, 2019 at Messe München and will now cover 10 exhibition halls, making it Europe’s largest energy industry event. This growth is due in large part to the upward trend in renewable energies. Since 2010, the proportion of energy generated worldwide from renewable sources has risen from 20 to 25 percent. By 2030, we’re looking at a jump to around 60 percent. In Germany, an average of 45 percent of all electricity generated already came from renewables in the first quarter of 2019. This dynamism is stimulating innovation and shaping the modern energy industry. The buzzword of the hour is sector coupling – a unification of the previously independent electricity, heating and transportation sectors. For instance, a photovoltaic (PV) installation in

The “One and Done” Era for Orphan Drugs: Evaluate Predicts 12% Growth, Driven by New Technologies, but Benefits Go to Big Pharma25.4.2019 07:00:00 CESTPressemelding

Scientific advancements will help propel the orphan drug market to a 12% CAGR to 2024, double the 6% rate expected for non-orphan products. In addition to recent breakthrough cell and gene therapy products like Yescarta and Luxturna, a number of “one and done” treatments for orphan diseases are approaching the market, including Novartis’s Zolgensma and bluebird bio’s Lentiglobin. The explosion of new technologies brings their high price points into greater focus — for example, the $425,000 per eye list price for Spark’s Luxturna is the value-based price agreed on with Spark and payers. In 2018, the mean cost for an orphan drug was 4.5 times that of a non-orphan product. Despite the clear advancements in treatment, however, those calling for reform of the Orphan Drug Act may gain further ammunition. Big pharma continues to entrench their position in the orphan market, as evidenced by Bristol-Myers Squibb’s bid for Celgene, Roche’s pending acquisition of Spark, and Novartis’s $8.7bn paym

NTT Group Increases Capital in NTT Global Data Centers Corp. to Further Strengthen Data Center Business25.4.2019 06:00:00 CESTPressemelding

NTT Communications Corporation (NTT Com), the ICT solutions and international communications business within the NTT Group (TOKYO:9432), NTT Urban Development Corporation, Nippon Telegraph and Telephone Corporation (NTT Corporation), NTT Finance Corporation announced today that it has increased its capital in NTT Global Data Centers Corporation (NTT GDC), a subsidiary company handling centralized global construction, management and equipment wholesales for NTT group data centers. NTT GDC is capitalized at 1.25 billion JPY, of which 60% will be had share by NTT Com. And three other NTT Group companies newly acquired shares in NTT GDC, namely, NTT Urban Development Corporation (20%), NTT Corporation (10%) and NTT Finance Corporation (10%), all as of today. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190424006195/en/ NTT GDC oversees investment and asset-ownership functions for data center construction. Established last year

China Yiwu Imported Commodities Fair 2019 to Open in May25.4.2019 05:49:00 CESTPressemelding

China Yiwu Imported Commodities Fair 2019, the professional platform for international small commodities to enter China, will open on May 23-26, 2019 at the Yiwu International Expo Center in China’s small commodities paradise Yiwu City. The Fair of this year will cover an exhibition area of over 50,000 square meters, providing 2,000 international standard booths in 4 exhibition zones, namely Asia Pavilion I, Asia Pavilion II, European Pavilion and America-Australia-Africa & Cross-border Trade Pavilion. The imported commodities to be displayed will include household items, maternal and child supplies, beauty and personal care, crafts, home appliances, food and beverage, health and nutrition, fashion accessories, creative toys, stationery, sports goods, clothing and accessories. The Fair is expected to attract over 1,500 business companies and organizations from over 100 countries and regions across the world. The number of visitors and buyers will exceed 120,000. The Import Commodities

Biomedical Software Startup BostonGene Secures $50M in Series A Financing from NEC25.4.2019 01:00:00 CESTPressemelding

NEC Corporation (NEC; TSE: 6701) and BostonGene Corporation (BostonGene), a Boston, Mass-based biomedical software company, today announced a US$50M series A strategic investment in BostonGene by NEC. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190424006170/en/ BostonGene, a pioneer in the use of biomedical software for advanced patient analysis, has discovered, developed, and patented a holistic approach to cancer treatment by defining the optimal therapy combination for individual patients, with a particular focus on immuno- and targeted therapies. BostonGene’s solution includes: Genome and transcriptome sequencing methods to create a patient’s molecular profile. Algorithms that estimate the immune fitness and cancer characteristics of a patient. A continuously updated expert-curated and Artificial Intelligence (AI)-driven database of cancer research and clinical information. Cloud-native software that delivers a patien

ABS, Google Cloud and SoftServe Partner to Demonstrate Feasibility of AI-enabled Corrosion Detection24.4.2019 15:57:00 CESTPressemelding

ABS, Google Cloud and SoftServe completed a pilot project applying artificial intelligence (AI) models to detect levels of corrosion and coating breakdown on ships and offshore structures. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190424005822/en/ ABS, Google Cloud and SoftServe Partner to Demonstrate Feasibility of AI-enabled Corrosion Detection (Photo: Business Wire) The project successfully demonstrated the accuracy of AI in detecting and assessing structural anomalies commonly found during visual inspection. AI techniques could be further used to analyze images over time to understand corrosion and coating breakdown trends. “Digital innovation in AI will change how surveys and maintenance strategies are executed, driving more condition-based approaches to class and maintenance,” said ABS Chairman, President and CEO, Christopher J. Wiernicki. “We are building a future in which digital tools can remotely assess the co